Medical mushrooms used for biochemical failure after radical treatment for prostate cancer: An open-label study

International Journal of Urology

Volumn 17, Issue 6, 2010, Pages 548-554

  Yoshimura, Koji ^a   Kamoto, Toshiyuki ^b   Ogawa, Osamu ^a   Matsui, Shigeyuki ^c   Tsuchiya, Norihiko ^d   Tada, Harue ^a   Murata, Keiko ^a   Yoshimura, Kenichi ^a   Habuchi, Tomonori ^d   Fukushima, Masanori ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c INSTITUTE OF STATISTICAL MATHEMATICS   (Japan)

^d AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Complementary medicine; Prostate caner; Prostate specific antigen; Prostatectomy; Radiation

Indexed keywords

AGARICUS BLAZEI EXTRACT; GANODERMA LUCIDUM EXTRACT; PROSTATE SPECIFIC ANTIGEN; ROKKAKU REISHI; SENSEIRO; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; AGARICUS BLAZEI; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCHEMISTRY; BLOOD TOXICITY; BONE MARROW TOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CORRELATION ANALYSIS; DIARRHEA; DIET SUPPLEMENTATION; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; FATIGUE; GANODERMA LUCIDUM; GASTROINTESTINAL SYMPTOM; HEARTBURN; HUMAN; JAPAN; LEUKOCYTOSIS; LIVER INJURY; LUNG INFILTRATE; MALE; MUSCULOSKELETAL DISEASE; MYALGIA; PNEUMONIA; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RASH; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL; TREATMENT FAILURE; TREATMENT RESPONSE; VOICE; AGARICUS; AGED; ALTERNATIVE MEDICINE; BLOOD; MIDDLE AGED; PROSTATIC NEOPLASMS; VERY ELDERLY;

AGARICUS; AGED; AGED, 80 AND OVER; COMPLEMENTARY THERAPIES; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REISHI; TREATMENT FAILURE;

EID: 77952684176     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2010.02528.x     Document Type: Article

References (17)

1. National Center for Complementary and Alternative Medicine in National Institutes of Health. What is complementary and alternative medicine? Cited 1 April 2009.] Available from URL: http://nccam.nih.gov/health/whatiscam/
2. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N. Engl. J. Med. 1993 328: 246 252.
3. Hyodo I, Amano N, Eguchi K et al. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J. Clin. Oncol. 2005 23: 1 10.
4. Yoshimura K, Ueda N, Ichioka K, Matsui Y, Terai A, Arai Y. Use of complementary and alternative medicine by patients with urologic cancer: a prospective study at a single Japanese institution. Support. Care Cancer 2005 13: 685 690.
5. Yoshimura K, Ichioka K, Terada N, Terai A, Arai Y. Use of complementary and alternative medicine by patients with localized prostate carcinoma: study at a single institute in Japan. Int. J. Clin. Oncol. 2003 8: 26 30.
6. Yu CH, Kan SF, Shu CH, Lu TJ, Sun-Hwang L, Wang PS. Inhibitory mechanism of Agaricus blazei Murill on the growth of prostate cancer in vitro and in vivo. J. Nutr. Biochem. 2009 20: 753 764.
7. Van Patten CL, de Boer JG, Guns EST. Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence. J. Urol. 2007 180: 2314 2322.
8. American society for therapeutic radiology and oncology consensus panel. Consensus statement: guidelines for PSA following radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 1997 37: 1035 1041.
9. Japan Clinical Oncology Group. National Cancer Institute Common Toxicity Criteria, Japanese version 2 Cited 1 April 2009.] Available from URL: http://www.jcog.jp/doctor/tool/C-150-0011.pdf
10. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999 281: 1591 1597.
11. Wolk A. Diet, lifestyle and risk of prostate cancer. Acta Oncol. 2005 44: 277 281.
12. Ornish D, Weidner G, Fair WR et al. Intensive lifestyle changes may affect the progression of prostate cancer. J. Urol. 2005 174: 1065 1069.
13. Frattaroli J, Weidner G, Dnistrian AM et al. Clinical events in prostate cancer lifestyle trial: results from two years of follow-up. Urology 2008 72: 1319 1323.
14. Ahn WS, Kim DJ, Chae GT et al. Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy. Int. J. Gynecol. Cancer 2004 14: 589 594.
15. Hetland G, Johnson E, Lyberg T, Bernardshow S, Tryggestad AM, Grinde B. Effects of the medical mushroom Agaricus blazei Murill on immunity, infection and cancer. Scand. J. Immunol. 2008 68: 363 370.
16. Cookson MS, Aus G, Burnett AL et al. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for localized prostate cancer update panel report and recommendations for a standard in the reporting of surgical outcomes. J. Urol. 2007 177: 540 545.
17. Arlen PM, Bianco F, Dahut WL et al. Prostate specific antigen working group guidelines on prostate specific antigen doubling time. J. Urol. 2008 179: 2181 2186.